cycloheximide has been researched along with ml106 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DS; Kim, SY; Lee, D; Lee, SH; Lee, T; Min, KH; Park, KC; Shin, JS | 1 |
1 other study(ies) available for cycloheximide and ml106
| Article | Year |
|---|---|
A derivative of imidazobenzimidazole, ML106, inhibits melanin synthesis via p38 MAPK activation.
Topics: Animals; Benzimidazoles; Blotting, Western; Cell Line, Tumor; Cell Survival; Cycloheximide; Enzyme Activation; Melanins; Melanoma; Mice; Monophenol Monooxygenase; p38 Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Signal Transduction | 2014 |